Structural Heart

This structural heart channel includes news, videos, podcasts and other content related to diagnosis and treatment of structural heart disease. Topics covered include heart valve repair and replacement, transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve replacement (TTVR), left atrial appendage (LAA) occlusion, heart failure interventional device therapies, and closing holes in the heart using, including occlusion of atrial septal defects (ASDs), ventricular septal defects (VSDs) and patent foramen ovales (PFOs).

Technology | Heart Valve Technology

September 24, 2019 – Medtronic announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Evolut ...

Home September 24, 2019
Home
News | Congenital Heart

September 20, 2019 – Abbott announced approvals in Europe for two of its pediatric devices — the Masters HP 15mm ...

Home September 20, 2019
Home
News | Leads Implantable Devices

September 20, 2019 — BioTrace Medical Inc. announced the company’s key activities at the 31st annual Transcatheter ...

Home September 20, 2019
Home
News | Heart Failure

September 12, 2019 — Corvia Medical has sponsored and is actively enrolling patients in a heart failure (HF) device ...

Home September 12, 2019
Home
News | Heart Valve Technology

September 5, 2019 — Abbott announced the launch of the company's TRILUMINATE Pivotal trial evaluating the safety and ...

Home September 05, 2019
Home
The most popular cardiac technology news in August 2019 was the FDA clearance for a new indication for both the Edwards Sapien 3 and Medtronic CoreValve transcatheter aortic valve replacement (TAVR) devices for low-risk patients. This puts the technology on equal footing with the previous standard-of-care of open heart surgery, representing a paradigm shift in cardiology.
Feature | Dave Fornell, Editor

September 3, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home September 03, 2019
Home
News | Left Atrial Appendage (LAA) Occluders

August 28, 2019 — AtriCure Inc. announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of ...

Home August 28, 2019
Home
An illustration of the BASILICA procedure showing the leaflet of the original bioprosthetic valve sliced open to allow coronary blood flow after implantation of a TAVR valve. The new TAVR valve can push the leaflets of the bioprosthetic valve upwards, blocking the coronary arteries. During the BASILICA procedure, a catheter directs an electrified guidewire through the base of the left aortic cusp into a snare in the left ventricular outflow tract (LVOT). After snare retrieval, the mid-shaft of the guidewire
Feature | Heart Valve Technology

A novel technique has proven successful in preventing coronary artery obstruction during transcatheter aortic valve ...

Home August 27, 2019
Home
News | Heart Valve Technology

August 22, 2019 — Edwards Lifesciences is recalling the Sapien 3 Ultra delivery system after receiving reports of burst ...

Home August 22, 2019
Home
FDA Approves Sapien 3, CoreValve Evolut TAVR Valves for Low-risk Patients
Feature | Heart Valve Technology | Jeff Zagoudis, Associate Editor, and Dave Fornell, Editor

August 16, 2019 — In one coordinated move, the U.S. Food and Drug Administration (FDA) opened use of transcatheter ...

Home August 16, 2019
Home
Example of an aortic valve CT imaging workup for TAVR valve sizing and assessing access routes. This patient has an aneurysm in the aortic arch. Image from GE Healthcare.
Feature | Structural Heart | Ashish Pershad, M.D., and Kenith Fang, M.D., FACS

As we usher in a new era for treating patients with aortic stenosis, we have been reflecting on the evolution of the ...

Home August 12, 2019
Home
Subscribe Now